Landscapes / Companies

Corregene Biotechnology Co., Ltd not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 1
 
Next date
CRTE7A2-01 TCR-T Cell, Phase 1 trial completes
Drugs
4
in active trials · 5 in all
Trials
4 active
5 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
—
Phase 1 31 Dec 2027Phase 1 trial completes
—
Phase 1 30 Nov 2028Phase 1 trial completes
—
Phase 1 30 Dec 2029Phase 1 trial completes
—
Phase 1 30 Mar 2030Phase 1 trial completes

About

No active trial
Interleukin-2
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Corregene Biotechnology Co., Ltd

Following is part of Solo: you see every change to Corregene Biotechnology Co., Ltd the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in